Improving non-nucleoside reverse transcriptase inhibitors for first-line treatment of HIV infection: the development pipeline and recent clinical data.
about
Antiviral activity and in vitro mutation development pathways of MK-6186, a novel nonnucleoside reverse transcriptase inhibitorSynthesis, biological evaluation and 3D-QSAR studies of 3-keto salicylic acid chalcones and related amides as novel HIV-1 integrase inhibitors.Design, synthesis, and evaluation of diarylpyridines and diarylanilines as potent non-nucleoside HIV-1 reverse transcriptase inhibitors.TMC278, a next-generation nonnucleoside reverse transcriptase inhibitor (NNRTI), active against wild-type and NNRTI-resistant HIV-1.Antiviral activity of MK-4965, a novel nonnucleoside reverse transcriptase inhibitor.
P2860
Improving non-nucleoside reverse transcriptase inhibitors for first-line treatment of HIV infection: the development pipeline and recent clinical data.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Improving non-nucleoside rever ...... line and recent clinical data.
@ast
Improving non-nucleoside rever ...... line and recent clinical data.
@en
type
label
Improving non-nucleoside rever ...... line and recent clinical data.
@ast
Improving non-nucleoside rever ...... line and recent clinical data.
@en
prefLabel
Improving non-nucleoside rever ...... line and recent clinical data.
@ast
Improving non-nucleoside rever ...... line and recent clinical data.
@en
P1476
Improving non-nucleoside rever ...... line and recent clinical data.
@en
P2093
Klaus Klumpp
Zachary K Sweeney
P304
P577
2008-07-01T00:00:00Z